INTERNATIONAL PATENT: BEIJING CHANGPING LABORATORY, 北京昌平实验室 FILES APPLICATION FOR "CANCER IMMUNOTHERAPY STRATEGY TARGETING VIRUS-SPECIFIC BYSTANDER T CELL WITHIN TUMOR"

GENEVA, Aug. 10 -- BEIJING CHANGPING LABORATORY (Yard 28, Science Park RoadChangping District, Beijing 102206), 北京昌平实验室 (中国北京市昌平区科学园路28号) filed a patent application (PCT/CN2025/075162) for "CANCER IMMUNOTHERAPY STRATEGY TARGETING VIRUS-SPECIFIC BYSTANDER T CELL WITHIN TUMOR" on Jan 26, 2025. With publication no. WO/2025/162368, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Xia...